Detalhe da pesquisa
1.
Occurrences and Outcomes of Immune Checkpoint Inhibitors-Induced Vitiligo in Cancer Patients: A Retrospective Cohort Study.
Drug Saf
; 43(2): 111-117, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31630381
2.
Safety of immune checkpoint inhibitor rechallenge after discontinuation for grade ≥2 immune-related adverse events in patients with cancer.
J Immunother Cancer
; 8(2)2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33428586